THC-free, daily, immunity CBD gummies: how to read a range

A range of CBD gummies is generally broken down along four lines: the intended use (morning, evening, sport), the accompanying formulation (melatonin, vitamins, plants), the cannabinoid spectrum (THC-free isolate or full spectrum), and the dosage, which shifts the unit price. This segmentation remains strictly governed by law: no label may carry a health claim not validated by EFSA for CBD.

A "THC-free" gummy is formulated from CBD isolate purified to 98-99% or from a broad-spectrum extract from which the THC has been removed downstream. The stated aim is to reduce the risk of a positive saliva test and to reassure consumers who are sensitive to any trace. But isolate does not benefit from the entourage effect claimed for full spectrum, an effect that has itself not been scientifically validated by EFSA, and a "THC-free" mention without a certificate of analysis has no legal value.

The Court of Cassation, in its judgment of 21 June 2023, recalled that the legality of a product does not exempt a driver from an offence if THC is detected in a test. A quality isolate reduces that risk without removing it entirely.

A "daily" or "daily wellness" gummy is aimed at background use, with a generally moderate CBD dosage (5-25 mg). The concept is commercial, not legal: no "daily balance" or "daily support" mention attached to CBD relies on a claim validated under Regulation (EC) No 1924/2006.

An "immunity" gummy often combines CBD and vitamins (C, D), sometimes zinc. Only vitamins and minerals can carry an immune claim validated in the European register: the mention is admissible only if it rests on that composition, never on CBD alone.

Whatever the segment, an ingested CBD gummy falls under the Novel Food regime. EFSA has issued no authorisation for CBD to date and published on 9 February 2026 a provisionally safe daily dose of around 2 mg/day for a 70 kg adult. Since 15 May 2026, the DGAL has been applying this framework strictly: gummies, capsules, ingested oils and CBD drinks without European validation are being withdrawn from the market.

The segments still active in France remain numerous: industrial hemp flowers and resins with THC ≤ 0.30%, TPD-compliant e-liquids, cosmetics (creams, balms, sticks), oils repositioned outside the food category, and food supplements without CBD.

Four criteria make it possible to assess a range seriously: the declared cannabinoid spectrum (isolate, broad, full), the CBD dosage per unit confirmed by a certificate of analysis, the nature of the claims (factual or marketing), and the legal status of the product (ingested or not). A transparent product displays these elements clearly and gives access to its CoA online. Our CBD buying guide sets out these criteria in greater depth.

CBD is not a medicine. In case of regular use or doubt, consult a healthcare professional.

Does a "THC-free" gummy guarantee a negative saliva test?

No. The mention indicates a content below common analytical thresholds, but a highly sensitive test may detect residual traces. A quality isolate reduces the risk, it does not cancel it out.

Is a "daily wellness" gummy more highly dosed than a standard gummy?

Not automatically. The mention reflects a positioning around regular use rather than a particular dosage. Only the content in mg per unit, stated on the label or the certificate of analysis, makes it possible to compare two products.

Does an "immunity" range without vitamins have any legal standing?

No. No immune claim is validated for CBD alone. A credible "immunity" formulation rests on vitamins and minerals with a confirmed EFSA claim, such as vitamin C or zinc.

How can you tell whether a gummy meets the Novel Food filter?

Ask the manufacturer for proof of a European Novel Food authorisation. Without that document, the product should no longer have been sold in France in the ingested category since 15 May 2026.